One Clinical Trial Management Platform
No longer manage across disconnected silos. Operate within one unified platform designed for regulated environments.
The Medidata Platform aligns the Patient, Data, and Study Experiences into one continuous, governed system, so you accelerate start-up, strengthen data quality, and deliver faster, more approval-ready submissions at scale.
How We Deliver
What Others Can’t
When you need one partner to simplify complexity, embed AI into execution, and scale globally, Medidata delivers for you what others can’t.
One Architecture
Most platforms integrate products. Medidata integrates experiences in one architecture.
Your trials operate on one unified user experience, one data foundation, one governance framework, one security and compliance model.
AI for Impact
Built for clinical trials, our AI is trained on 38,000+ validated studies and 12+ million patients.
Embedded in unified workflows, it doesn’t just analyze, it acts—simulating outcomes and recommending next best actions.
Built for Global Scale
As a Dassault Systèmes brand, we operate within a global technology leader serving 350,000+ customers across highly regulated industries.
The same enterprise-grade infrastructure and virtual modeling discipline trusted in aerospace and advanced manufacturing now strengthens your clinical research.
Experiences
on One Platform
Point solutions only improve isolated tasks. Connecting Experiences enhances the entire trial by creating a continuously integrated, end-to-end system.
The Medidata Patient, Data, and Study Experiences are at the intersection of trial success.
Select each to see how they connect across the platform.
What Sponsors, CROs, and Sites Say
Reducing Burdens for Sites:
Medidata’s Single Platform
“The full suite of solutions within one platform was the draw for us. We wouldn’t have the complaint [from site partners], ‘I’m a site in a trial and I have to log into 10 different systems and platforms, and each vendor has its own system with a different login and password.’ That’s too complicated for our sites. We minimize the number of platforms that we use for a study—one login, maybe two—reducing complexity and improving usability for sites so that they want to continue to work with us.”
Christina Villar
Head of Clinical Affairs
The Importance of Speed in Consolidating Data in Rare Disease Studies
“[Sponsors in the rare disease or biotech space] need cutting edge [solutions] that can adapt to extremely complicated [clinical trials]. The challenges are unique—the patient population is much smaller, but, within the volume of data that you’re collecting, each piece of data that comes in is all the more critical. [Medidata] can consolidate that data into a single platform that analyzes it quickly and can help pivot to changing strategies for a particular clinical program. This is very important.”
Kathy Zheng
Director Project Management and Clinical Innovations
Transitioning to Medidata Has Improved the Quality of Data
“The transition over to the Medidata Platform has enabled us to follow the provenance of data, from point of collection all the way to monitoring, tracking, and reporting, in a way that we weren’t able to do before.
We’ve been able to improve the quality of the data that we’ve been getting out of studies.”
Jay Jantz
Director of Clinical Data Analytics
Awards and Recognition
2024
IDC MarketScape Worldwide Life Science R&D DCT Technology Solutions and Consulting Services
2025
Medidata x Cogstate Partnership
Best Clinical Trial Technology Solution Provider
2023 & 2024
Everest Group Life Sciences Clinical Data and Analytics (D&A) Platforms
2022 & 2023
Everest Group Decentralized Clinical Trial Platforms